Skip to content
10-K

Annual Report

INTERLEUKIN GENETICS INC

0001144204-16-088456

← back to feed
Filed
Mar 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 16, 2016 172.95M sh
Capex FY 2015 · Dec 31, 2014 $98.03K
Long Term Debt FY 2015 · Dec 31, 2014 $4.74M
Short Term Debt FY 2015 · Dec 31, 2014 $0
Stockholders Equity FY 2015 · Dec 31, 2014 $4.52M
Stockholders Equity FY 2015 · Dec 31, 2013 $5.25M
Current Liabilities FY 2015 · Dec 31, 2014 $4.01M
Total Liabilities FY 2015 · Dec 31, 2014 $8.75M
Current Assets FY 2015 · Dec 31, 2014 $12.18M
Total Assets FY 2015 · Dec 31, 2014 $13.27M
Sga Expense FY 2015 · Dec 31, 2014 $5.77M
Rd Expense FY 2015 · Dec 31, 2014 $843.1K
Net Income FY 2015 · Dec 31, 2014 −$6.34M
Operating Income FY 2015 · Dec 31, 2014 −$6.33M
Gross Profit FY 2015 · Dec 31, 2014 $374.94K
Cost Of Revenue FY 2015 · Dec 31, 2014 $1.44M
Revenue FY 2015 · Dec 31, 2014 $1.81M
Stock Issued FY 2015 · Jun 30, 2014 18.21M sh
Cash And Equivalents FY 2015 · Dec 31, 2013 $7.54M